Posts by Carolyn Hoffman
RESTORING BALANCE TO THE BRAIN’S MOST FRAGILE CHEMISTRY
Click the link below to read the article highlighting Galibra Neuroscience, as it appears on the cover of the Life Science Review Journal. In the article Galibra Neuroscience founders Drs.…
Read MoreDr. Phil Pearl’s Podcast on Metabolic Epilepsies
Phillip L. Pearl, MD is Director of Epilepsy and Clinical Neurophysiology and William G. Lennox Chair in the Department of Neurology at Boston Children’s Hospital and Professor of Neurology at…
Read MoreGalibra Neuroscience announces capsid license agreement for Gene Therapy
The SSADH Association funded the creation of a new mouse model to be created at Boston Children’s Hospital by Alexander Rotenberg, MD PhD and Henry Lee, MPhil, PhD. This mouse…
Read MoreSTTR Grant to Galibra and Boston Children’s Hospital
Galibra Neuroscience has been awarded $500,000 through the U.S. Department of Health and Human Services. This grant through the Small Business Technology Transfer (STTR) program is to encourage research and…
Read MoreDr. Rotenberg is named 2025 Harrington Scholar-Innovator Award recipient.
Congratulations to Alexander Rotenberg, MD, PhD. for being named one of ten 2025 Harrington Scholar-Innovator Award recipient by the Harrington Discovery Institute, for his project titled ‘Gene therapy for a…
Read MoreCelebrating Rare Disease Day
Wisconsin mother creates SSADH Association after her son is diagnosed with neuro disorder. Spectrum News Wisconsin | BY Abbey Taylor | PUBLISHED 12:59 PM ET Feb. 26, 2025 OCONOMOWOC, Wis. —…
Read MoreDr. Lee’s Podcast on Gene Therapy for SSADH Deficiency
Dr. Henry Lee, Ph.D., Boston Children’s Hospital, F.M. Kirby Neurobiology Center joins the Journal of Inherited Metabolic Disease (JIMD) podcast. Dr. Lee discusses the challenges of developing gene therapies for…
Read MoreSSADHD Presentation at PAME
Charity Adams (Mom to Bond), Dr. Phil Pearl and Dr. Itay Tokatly Latz spoke at the 2024 PAME (Partners Against Morality in Epilepsy) event on December 5th in Los Angeles,…
Read MoreNatural History Study Expanded to 10 Years
We are thrilled to announce that the grant for the SSADH Deficiency Natural History Study was renewed by the National Institutes of Health (NIH) to allow collection of more data…
Read MoreSSADHD: a metabolic and genomic approach to diagnosis
Genomic sequencing offers an untargeted, data-driven approach to genetic diagnosis; however, variants of uncertain significance often hinder the diagnostic process. The discovery of rare genomic variants without previously known functional…
Read More